Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$9.29 USD
-0.31 (-3.23%)
Updated May 17, 2024 04:00 PM ET
After-Market: $9.30 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | -0.09 |
Last EPS Surprise | 52.63% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.39 |
Next Year | 0.26 |
EPS (TTM) | -0.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.85M | 16.99M | 82.26M | 105.57M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 16.30M | 17.15M | 114.74M | 130.59M |
Low Estimate | 15.54M | 16.83M | 65.95M | 87.31M |
Year ago Sales | 13.75M | 15.69M | 57.42M | 82.26M |
Year over Year Growth Est. | 15.27% | 8.30% | 43.26% | 28.33% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | -0.05 | -0.39 | 0.26 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.16 | -0.07 | -0.45 | 0.09 |
High Estimate | -0.09 | -0.03 | -0.23 | 0.77 |
Low Estimate | -0.16 | -0.07 | -0.48 | -0.08 |
Year ago EPS | -0.13 | -0.01 | -0.39 | -0.39 |
Year over Year Growth Est. | 0.00% | -400.00% | 0.00% | 165.81% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | -0.05 | -0.39 | 0.26 |
7 Days Ago | -0.13 | -0.05 | -0.39 | 0.26 |
30 Days Ago | -0.13 | -0.05 | -0.39 | 0.26 |
60 Days Ago | -0.13 | -0.05 | -0.38 | 0.29 |
90 Days Ago | -0.11 | -0.04 | -0.15 | 0.37 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.13 | -0.05 | -0.39 | 0.26 |
Zacks Consensus Estimate | -0.13 | -0.05 | -0.39 | 0.26 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.09 | 0.03 | -0.01 | -0.13 | NA |
Estimate | -0.19 | -0.04 | -0.10 | -0.16 | NA |
Difference | 0.10 | 0.07 | 0.09 | 0.03 | 0.07 |
Surprise | 52.63% | 175.00% | 90.00% | 18.75% | 84.10% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more